Together, these observations indicate that management of complement expression, especially those derived from C3, is important, particularly the latter part of pregnancy, and suggest that complement systems could be a potential therapeutic target for the treatment of pregnancy disorders originating from complement dysregulation. The gene discussed is C3; the disease is pregnancy disorder.